Niracle, Llc

Founded in 2010, NiRACLE is an innovative Contract Research Organization (CRO), providing Near Infrared (NIR) method development, Process Analytical Technology (PAT), Quality by Design (QbD), and process validation support to the pharmaceutical industry. NiRACLE has pioneered the Supervised Principal Component Analysis (SPCA) technology, a novel multivariate data analysis approach that can be used in NIR-related quantitative analysis (US Patent No. US2011/ 0216313 A1). NiRACLE’s services let the clients build high degree of assurance in their manufacturing processes through historical data mining, modeling, and trend analysis, identification of critical product and process attributes, design of experiments, and defining the design space. NiRACLE’s expertise will help clients to achieve key milestones, speed up product development, and lower R&D and production costs. NiRACLE maintains strict confidentiality to client’s intellectual properties. NiRACLE’s scientists are motivated to deliver the highest values to the clients. Together as a team, they will work closely with clients to generate the best possible results, project by project.